J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Gram-positive infections: lessons learnt and novel solutions

New epidemiology of Staphylococcus aureus infection in Asia

Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors S. Amit, H. Mishali, T. Kotlovsky,

G. Cornaglia, A. Lönnroth, M. Struelens

M.F.Q. Kluytmans-VandenBergh, J.A.J.W. Kluytmans

Incidence and outcome of Staphylococcus aureus endocarditis—a 10-year single-centre northern European experience H. Asgeirsson, A. Thalme, M. Kristjansson,

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.

European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Migrant health—a cause for concern?

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

Clinical impact of antibiotic-resistant Gram-positive pathogens

Cost-effectiveness of universal MRSA screening on admission to surgery

Clonal complex 398 methicillin-susceptible Staphylococcus aureus bloodstream infections are associated with high mortality K. Bouiller, H. Gbaguidi-Haore,

European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after.

Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals

Clinical impact and prevalence of MRSA CC398 and differences between MRSA-TetR and MRSA-TetS in an area of Spain with a high density of pig farming: a.

Longitudinal investigation of nasopharyngeal methicillin-resistant Staphylococcus aureus colonization in early infancy: The PATCH birth cohort study

Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012 V.

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

W. Witte, B. Pasemann, C. Cuny Clinical Microbiology and Infection

Molecular mechanism of gentamicin resistance in Bartonella henselae

Do we need new antibiotics?

Spa typing directly from a mecA, spa and pvl multiplex PCR assay—a cost-effective improvement for methicillin-resistant Staphylococcus aureus surveillance

Clonal dissemination of epidemic methicillin-resistant Staphylococcus aureus in Belgium and neighboring countries A. Deplano, W. Witte, W.J. Van Leeuwen,

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

P. Seng, J.M. Rolain, D. Raoult, P. Brouqui

A variant of the Southern German clone of methicillin-resistant Staphylococcus aureus is predominant in Croatia A. Budimir, R.H. Deurenberg, Z. Bošnjak,

Bacterial resistance—the clinical challenge

Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia M. Bassetti, E.M. Trecarichi, A. Mesini,

Evaluation of three chromogenic media (MRSA-ID, MRSA-Select and CHROMagar MRSA) and ORSAB for surveillance cultures of methicillin-resistant Staphylococcus.

Strategies for managing today's infections

Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis R. Diaz, V. Afreixo,

S. Imbert, J.-Y. Brossas, M. Palous, I. Joly, I. Meyer, A. Fekkar

Transmissibility of livestock-associated methicillin-resistant Staphylococcus aureus (ST398) in Dutch hospitals M.W.M. Wassenberg, M.C.J. Bootsma, A.

M. Aires-de-Sousa Clinical Microbiology and Infection

Spread of Staphylococcus aureus clinical isolates carrying Panton–Valentine leukocidin genes during a 3-year period in Greece V. Chini, E. Petinaki,

Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals E.E. Udo, N. Al-Sweih, B.

Systematic review of antibiotic consumption in acute care hospitals

Y. Tveten, A. Jenkins, A.G. Allum, B.-E. Kristiansen

Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.

Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000 T. Benfield, F. Espersen,

Antibacterial drug discovery in the 21st century

Can β-lactams be re-engineered to beat MRSA?

Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals G.L. Cartolano,

A.W. Karchmer Clinical Microbiology and Infection

P.M. Hawkey Clinical Microbiology and Infection

Strain relatedness of meticillin-resistant Staphylococcus aureus isolates recovered from patients with repeated bacteraemia C-H. Liao, C-C. Lai, S-Y.

Evolving problems with resistant pathogens

C. Tamalet, P. Colson, E. Decroly, C. Dhiver, I. Ravaux, A. Stein, D

Epidemiological relatedness of methicillin-resistant Staphylococcus aureus from a tertiary hospital and a geriatric institution in Spain E. Ruiz de Gopegui,

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

Clinical Microbiology and Infection

Predictors of clinical and microbiological treatment failure in patients with methicillin- resistant Staphylococcus aureus (MRSA) bacteraemia: a retrospective.

Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search.

Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus J.A.

Abstracts Clinical Microbiology and Infection

J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T

A. Manzur, F. Gudiol Clinical Microbiology and Infection

W. Witte Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

D.A. Robinson, M.C. Enright Clinical Microbiology and Infection

CMI readers' survey Clinical Microbiology and Infection

Presentation transcript:

Worldwide decrease in methicillin-resistant Staphylococcus aureus: do we understand something? J.-M. Rolain, C. Abat, P. Brouqui, D. Raoult Clinical Microbiology and Infection Volume 21, Issue 6, Pages 515-517 (June 2015) DOI: 10.1016/j.cmi.2015.04.017 Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions

Fig. 1 Current trends of methicillin-resistant Staphylococcus aureus (MRSA) infections in France and in Marseille hospitals according to different data sources from 2001 to 2015*. (a) 2001–2013 data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) invasive MRSA database (http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/Pages/database.aspx), France only. Duplicates have been removed from this database. (b) 2001–2015 data from the information management system of the four university hospitals of Marseille. These data only included data on bacteraemia due to MRSA strains. These data contained redundant data. (c) 1 January 2010 to 8 April 2015 data from the information management system of the four university hospitals of Marseille. These data only included data on bacteraemia and CSF infections due to MRSA strains. Duplicates have been removed from this database. CSF, cerebrospinal fluid; *data from 1 January 2015 to 8 April 2015. Clinical Microbiology and Infection 2015 21, 515-517DOI: (10.1016/j.cmi.2015.04.017) Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases Terms and Conditions